NATICK, MA — In an era marked by uncertainty in the life sciences sector, ABI-LAB has emerged as a beacon of stability and innovation. The company, which provides state-of-the-art lab spaces designed to accelerate the growth of early-stage and expanding life sciences companies, is a compelling success story that is particularly noteworthy in today’s volatile market.
In an exclusive Face-to-Face interview with Boston Real Estate Times, Gary Kaufman, Co-Founder and COO of ABI-LAB, discussed the company’s unique niche and the critical services it offers to life sciences startups and growing enterprises. Kaufman shared insights into the operational and strategic decisions that have enabled ABI-LAB to thrive despite broader industry challenges.
To watch the full interview, click here or on the image below.
Kaufman will also be a featured speaker at the Boston Life Sciences, Biotech, Pharma, and Medical Facilities Conference on April 17, 2025, at the Burlington Marriott Hotel in Burlington, MA. Hosted by Boston Real Estate Times and supported by Life Sciences Times, the event will run from 7:00 AM to 10:00 AM, bringing together industry leaders to explore emerging trends, opportunities, and challenges in life sciences, biotech, and healthcare facilities.
Tickets for the event can be purchased [here].
As the co-founder and COO of ABI-LAB, Kaufman has been instrumental in fostering biotech innovation. His extensive background includes over 30 years of entrepreneurial experience in consumer-focused businesses, real estate development, and the startup ecosystem. Kaufman is also an active angel investor and is currently developing an investment vehicle aimed at supporting two to four new biotech companies annually.
In addition to his work at ABI-LAB, Kaufman serves as the president of Shelby Enterprises Inc., a commercial and residential real estate firm. He is also the co-founder and vice chairman of the Metrowest Life Sciences Network, an organization dedicated to promoting professional networking and the growth of the life sciences industry in the Metrowest region of Massachusetts.
Kaufman holds a BS in Management Science from Bridgewater State College and has pursued advanced studies at Tel Aviv University and Harvard University. His diverse expertise has been pivotal in ABI-LAB’s success, particularly in providing scalable, flexible lab spaces for companies navigating the challenges of early-stage development.
Founded and headquartered in Natick, MA, ABI-LAB is redefining the way life sciences companies approach the crucial early phases of growth. The company recently celebrated the opening of its third facility, expanding its total footprint to 112,000 square feet. The new facilities feature cutting-edge innovation labs equipped with advanced instrumentation, deionized water, CO₂, gas, backup generators, and HVAC systems suitable for BL1 and BL2 applications. These fully equipped lab spaces remove significant operational and financial barriers for life sciences companies, enabling them to focus on what truly matters—innovation.
ABI-LAB’s dedication to supporting the growth of biotech, pharma, and medical companies underscores its commitment to fostering breakthroughs in the life sciences industry.
